Shen Zhen Weiguang Biological Products (002880.SZ) plans to establish a project company to build a market-oriented public service platform for cell and gene therapy in Shenzhen.

Shen Zhen Weiguang Biological Products (002880.SZ) announced that the company plans to establish Shenzhen Xihe Life Science and Technology Co., Ltd. (tentative name, subject to final registration by the industrial and commercial department) in partnership with Shenzhen Shine Biological Medicine Industry Development Co., Ltd. (referred to as Shine Biological), Shenzhen Cell Valley Biopharmaceutical Co., Ltd. (referred to as Cell Valley), and Shenzhen Saiqiao Biotechnology Co., Ltd. (referred to as Saiqiao Biotech). The purpose is to build a market-oriented public service platform for cell and gene therapy in Shenzhen. Xihe Life Science and Technology will have an initial registered capital of 100 million yuan, with the company subscribing for 40 million yuan, accounting for a 40% equity stake in Xihe Life Science and Technology. The project aims to establish a market-oriented public service platform for cell and gene therapy (CGT) with a core focus on the domestic market and simultaneous global market radiation. The core positioning is "empowering CGT marketization and standardization development," focusing on the entire industry chain of "plasmid-viral vector-cell drugs," establishing a production and inspection system in line with GMP standards, breaking industry bottlenecks, lowering industry thresholds, accelerating technology transfer, building a sustainable business ecosystem, and creating the most innovative demonstration effect of CGT public service platform nationwide. The construction and implementation of this project are important strategic initiatives for the company to extend its core advantages from the field of blood products to the forefront of biopharmaceuticals, which will help the company further improve its strategic layout in the biopharmaceutical field, nurture new business growth points, enhance the company's differentiation competitive advantage, and serve as an important lever for the company to achieve strategic upgrades and promote high-quality development.